How Can IV Therapy Help Manage Multiple Sclerosis Symptoms?

Our tailored IV infusions directly deliver fluids, vitamins, minerals, and targeted medications into the bloodstream, ensuring rapid absorption and immediate benefit. MS-related fatigue often stems from underlying dehydration, electrolyte imbalances, or nutrient deficiencies. By quickly restoring hydration and replenishing essential nutrients and electrolytes, Jean Walter Infusions helps patients regain their energy levels and reduce fatigue.

Additionally, our IV treatments frequently include specialized medications aimed at reducing inflammation and modulating the immune response. Chronic inflammation and immune dysregulation play a critical role in MS fatigue. Through carefully managed intravenous administration of corticosteroids or immunomodulatory therapies, we effectively decrease inflammation and help patients experience meaningful relief from persistent fatigue.

Furthermore, our team offers IV formulations enriched with essential vitamins and antioxidants, such as vitamin B-complex, vitamin C, and magnesium. These nutrients play an essential role in supporting mitochondrial function and cellular energy metabolism. By optimizing mitochondrial efficiency, our IV infusions help patients achieve improved energy production and lasting fatigue relief, with faster and more pronounced results than oral supplementation.

We know that fatigue in MS often arises from associated symptoms such as muscle spasms, pain, and disrupted sleep patterns. At Jean Walter Infusions, our comprehensive and safe IV treatments, not only directly target fatigue but also address these interconnected symptoms. By alleviating muscle tension, reducing pain, and enhancing sleep quality, we create an improved overall wellness experience, enabling patients to regain control over their daily lives.

Multiple sclerosis (MS) is a chronic neurological condition characterized by inflammation and damage within the central nervous system, often resulting in challenges with mobility and fatigue and significantly impacting quality of life. Patients frequently seek advanced treatment options and supportive therapies to manage symptoms and improve overall well-being. At Jean Walter Infusions, we provide medically supervised intravenous (IV) therapies designed specifically to help address MS-related symptoms, enhance patients’ quality of life, and support overall neurological health.

IV therapy involves administering medications, fluids, vitamins, antioxidants, and essential nutrients directly into the bloodstream. This method ensures optimal absorption and effectiveness, potentially helping to alleviate symptoms associated with MS, including fatigue, inflammation, and impaired mobility. Our practice specializes in offering evidence-based IV treatments tailored specifically to the needs of MS patients.

Medically recognized intravenous therapies play a crucial role in the comprehensive management of multiple sclerosis. For instance, IV corticosteroids (such as methylprednisolone) are commonly prescribed during acute MS relapses to rapidly reduce inflammation, shorten relapse duration, and facilitate quicker recovery of mobility and function. Additionally, disease-modifying therapies administered intravenously—including natalizumab (Tysabri), alemtuzumab (Lemtrada), and ocrelizumab (Ocrevus)—have proven effective in slowing disease progression, reducing neurological damage, and indirectly maintaining or improving mobility over the longer term.

We understand patients’ interest in complementary IV nutrient therapies, such as vitamin infusions, antioxidant-rich solutions, and hydration therapy. Although rigorous clinical trials specifically evaluating these nutrient infusions for mobility improvement in MS remain limited, anecdotal evidence and patient experiences suggest potential benefits of IV therapy, including increased energy levels, reduced fatigue, and overall feelings of improved well-being. Our practice emphasizes transparency and patient education, guiding individuals to understand the difference between medically validated, evidence-based treatments and complementary infusions that may offer supportive symptom relief but currently lack definitive clinical evidence for long-term mobility outcomes.

Jean Walter Infusions offers targeted intravenous treatments tailored to individuals living with MS. Our medically supervised IV therapies include evidence-based medications such as corticosteroids and disease-modifying agents that can, directly and indirectly, enhance mobility, reduce inflammation, and slow disease progression. We also provide complementary IV nutrient therapies aimed at addressing fatigue, boosting energy, and supporting general wellness.

At Jean Walter Infusions, we specialize in advanced intravenous (IV) therapies tailored specifically for patients managing multiple sclerosis (MS). Our personalized IV infusion treatments are designed to effectively address acute inflammation and relapse episodes common in MS, helping to rapidly alleviate neurological symptoms such as visual disturbances, numbness, weakness, and balance difficulties. We utilize intravenous corticosteroids, such as methylprednisolone, to significantly reduce inflammation, accelerate recovery following flare-ups, and help restore neurological function more effectively.

Additionally, Jean Walter Infusions prioritizes helping patients manage and reduce fatigue—a frequent and debilitating symptom of MS. Through targeted IV hydration, nutritional supplementation, and carefully selected medications administered intravenously, our patients routinely report increased energy, enhanced vitality, and improved overall well-being.

Our infusion therapies also focus on addressing spasticity and associated muscle stiffness or pain. By delivering specialized medications intravenously, we help to decrease involuntary muscle contractions, enhance mobility, and minimize discomfort, thereby significantly improving quality of life.

Moreover, our expert team provides intravenous immunoglobulin (IVIG) therapy, a powerful option for managing neuropathic pain and sensory symptoms commonly experienced by MS patients. IVIG treatments help modulate the immune system, reduce inflammation, and offer substantial relief from nerve-related discomfort.

Our comprehensive IV therapy approach is carefully customized for each patient’s unique needs, offering meaningful relief from acute exacerbations, fatigue, spasticity, pain, and other challenging MS symptoms—helping our patients regain their quality of life.

Multiple sclerosis occurs when the immune system mistakenly attacks the protective layers surrounding nerve fibers, causing inflammation, nerve damage, and a wide array of neurological symptoms. We administer targeted IV treatments that stabilize and rebalance immune responses, reducing inflammation and slowing disease progression.

One cornerstone of MS management at our practice includes intravenous delivery of immunomodulators and immunosuppressants. These innovative therapies—such as monoclonal antibodies (natalizumab, ocrelizumab, rituximab, alemtuzumab)—are carefully administered by our experienced clinicians. By specifically targeting immune cells or signaling pathways involved in MS, these medications reduce inflammation, prevent autoimmune attacks, and offer patients a greater quality of life.

To address acute MS exacerbations, Jean Walter Infusions offers intravenous corticosteroid treatments—primarily high-dose methylprednisolone—to rapidly suppress inflammation. Timely intervention with IV steroids effectively shortens relapse duration, reduces symptom severity, and helps patients recover faster, potentially limiting further nerve damage during acute inflammatory episodes.

Additionally, for patients who may have limited therapeutic options or sensitivities to first-line treatments, we offer intravenous immunoglobulin (IVIG). Derived from healthy donor plasma, IVIG therapy modulates immune function by neutralizing harmful antibodies, reducing inflammation, and regulating immune cell activity. Although typically reserved as a second-line or alternative treatment option, IVIG provides valuable therapeutic support for suitable patients at Jean Walter Infusions.

Our infusion-based approach ensures rapid, direct, and precise delivery of medication into the bloodstream, enhancing medication efficacy, reducing potential side effects, and improving overall patient outcomes. We prioritize personalized care, carefully selecting IV therapies based on each patient’s unique medical history, MS severity, and clinical considerations.

At Jean Walter Infusions, we recognize the challenges that come with living with Multiple Sclerosis, and our goal is to help you manage those challenges more effectively. With the guidance of Dr. Nasser Nasseri, MD, and our expert team, you can experience the relief and support you need to improve your quality of life. Our personalized IV therapy treatments are designed to provide you with the care you deserve, addressing your specific MS symptoms. For more information, contact us or book an appointment online. We have convenient locations to serve you. We serve patients from Rosedale MD, Columbia MD, Glen Burnie MD, Catonsville MD, North Baltimore MD, Edgewater MD, Parkville MD, Middle River MD, Dundalk MD, Halethrope MD, Ellicott City MD, Laurel MD, Hebbville MD, and Woodlawn MD.